Blood Global Hematology
Elsevier · United States
Aims & Scope✦ Inferred from recent articles
This journal publishes research on hematologic malignancies and disorders, including adult T-cell leukemia/lymphoma, chronic myeloid leukemia, sickle cell disease, hemophilia, and acute myeloid leukemia. Articles cover clinical case studies, treatment management, diagnostic tools, and implementation research, with a focus on diverse geographic regions and healthcare settings.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Blood Global Hematology
Is Blood Global Hematology a predatory journal?
PubScope has no integrity flags on record for Blood Global Hematology: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Blood Global Hematology?
Blood Global Hematology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Blood Global Hematology indexed in Scopus and Web of Science?
Blood Global Hematology is indexed in DOAJ.
How much does it cost to publish in Blood Global Hematology?
Blood Global Hematology charges an article processing charge (APC) of about $3,000 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref